Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • InMed Pharmaceuticals News

    0,2394 $ -5,38% -0,0136 $
    In : 0,2238 € | 19:33:12 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DTK2
    ISIN: CA4576376012
    US-Symbol: INM
    Typ: Aktie

    InMed Pharmaceuticals News

    04.01.23 - PR Newswire
    Thinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun?
    Thinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun? PR Newswire
    16.11.22 - PR Newswire
    Thinking about buying stock in Fast Radius, Camber Energy, InMed Pharmaceuticals, Taiwan Semiconductor, or Exela Technologies?
    Thinking about buying stock in Fast Radius, Camber Energy, InMed Pharmaceuticals, Taiwan Semiconductor, or Exela Technologies? PR Newswire
    14.09.22 - PR Newswire
    Thinking about buying stock in Aditxt, Scisparc, Akerna, InMed Pharmaceuticals, or Eos Energy?
    Thinking about buying stock in Aditxt, Scisparc, Akerna, InMed Pharmaceuticals, or Eos Energy? PR Newswire
    12.09.22 - PR Newswire
    Thinking about buying stock in American Virtual Cloud Technologies, Hess, Faraday Future Intelligent Electric, InMed Pharmaceuticals, or Rivian Automotive?
    Thinking about buying stock in American Virtual Cloud Technologies, Hess, Faraday Future Intelligent Electric, InMed Pharmaceuticals, or Rivian Automotive? PR Newswire
    03.05.22 - DGAP
    InMed Pharmaceuticals (INM): Notable launches of high-value rare cannabinoids
    Edison Investment Research Limited InMed Pharmaceuticals (INM): Notable launches of high-​value rare cannabinoids 03-May-2022 / 12:00 GMT/BST London, UK, 3 May 2022 ...
    29.11.21 - PR Newswire
    Thinking about buying stock in Adagio Therapeutics, 180 Life Sciences, InMed Pharmaceuticals, Beyondspring, or Inovio Pharmaceuticals?
    Thinking about buying stock in Adagio Therapeutics, 180 Life Sciences, InMed Pharmaceuticals, Beyondspring, or Inovio Pharmaceuticals? PR Newswire
    17.11.21 - PR Newswire
    Thinking about buying stock in Camber Energy, New Oriental Education, InMed Pharmaceuticals, Rockwell Medical, or IONQ Inc?
    Thinking about buying stock in Camber Energy, New Oriental Education, InMed Pharmaceuticals, Rockwell Medical, or IONQ Inc? PR Newswire
    21.10.21 - PR Newswire
    Thinking about buying stock in Nextplay Technologies, Sio Gene Therapies, Kadmon, Senseonics, or InMed Pharmaceuticals?
    Thinking about buying stock in Nextplay Technologies, Sio Gene Therapies, Kadmon, Senseonics, or InMed Pharmaceuticals? PR Newswire
    18.10.21 - PR Newswire
    Thinking about buying stock in Ion Geophysical, Valneva SE, Adamis Pharmaceuticals, Oyster Point Pharma, or InMed Pharmaceuticals?
    Thinking about buying stock in Ion Geophysical, Valneva SE, Adamis Pharmaceuticals, Oyster Point Pharma, or InMed Pharmaceuticals? PR Newswire
    13.09.21 - PR Newswire
    Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
    Cannabis Industry Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to ...
    07.09.21 - PR Newswire
    InMed Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com September 8th
    InMed Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com September 8th InMed Pharmaceuticals invites individual and institutional investors, as well as advisors ...
    02.09.21 - PR Newswire
    Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th
    Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th Cannabis Company Executives share vision, answer questions live at ...
    11.02.21 - PR Newswire
    InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
    InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results PR Newswire
    05.02.21 - PR Newswire
    InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results
    InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results PR Newswire
    05.02.21 - PR Newswire
    InMed Announces US$4.5 Million Private Placement
    InMed Announces US$4.5 Million Private Placement PR Newswire
    19.01.21 - PR Newswire
    InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe
    InMed Pharmaceuticals to Participate in 2021 Cannabinoid-​Derived Pharmaceuticals Industry Review Summit Europe PR Newswire
    08.01.21 - PR Newswire
    InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
    InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire
    05.01.21 - PR Newswire
    InMed to Participate at Virtual Conferences in January 2021
    InMed to Participate at Virtual Conferences in January 2021 PR Newswire
    03.12.20 - PR Newswire
    InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
    InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids PR Newswire
    25.11.20 - PR Newswire
    InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
    InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire

    Newssuche

    Videos

    08:40 Uhr +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »